Martin License Docarpamine for Chronic Liver Disease From Mitsubishi
03 Dec 2024 //
#N/A
Martin Pharma Presents Positive DREAM Study Results for Ascites
15 Nov 2024 //
PR NEWSWIRE
Martin Mackay’s rare disease startup gets $145 million as it enters the clinic
19 May 2020 //
ENDPTS